AGP Executive Report
Last update: 11 hours agoVaccine Trial: A revised hepatitis B study involving 14,000 newborns in Guinea-Bissau has won renewed ethics approvals. Half the babies would receive the vaccine at birth; the others would wait until six weeks. The government’s final authorization is still outstanding, and the WHO has criticized the study’s original design. Election Delay: ECOWAS is urging Guinea-Bissau’s military authorities to consult political parties and other stakeholders after the electoral commission said the December 6 vote cannot go ahead as planned. No replacement date has been announced, deepening doubts over the junta’s pledge to restore civilian rule.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
